UCHealth has released new guidance clarifying the current understanding of hormone therapy for menopause, addressing decades of confusion surrounding what many women still refer to as hormone replacement therapy (HRT). The health system’s updated patient education materials emphasize that modern hormone therapy, when appropriately prescribed, offers significant benefits for managing menopausal symptoms with manageable risks for many women.
The confusion around hormone therapy largely stems from the Women’s Health Initiative study released in 2002, which initially suggested increased risks of breast cancer and cardiovascular disease. That study led millions of women to discontinue treatment and created lasting fear around hormone use. However, subsequent analysis revealed the original findings were often misinterpreted, particularly regarding timing and the types of hormones used. Women who begin hormone therapy near menopause onset, typically in their 50s, face different risk profiles than older women who were included in the original study.
UCHealth’s guidance highlights that hormone therapy remains the most effective treatment for vasomotor symptoms like hot flashes and night sweats, which can significantly impact quality of life. The therapy can also help prevent bone loss and may reduce the risk of diabetes and colorectal cancer when used appropriately. Modern approaches favor lower doses, bioidentical hormones when possible, and individualized treatment plans based on each woman’s health history and symptom severity.
For patients navigating menopause, this updated information underscores the importance of having detailed conversations with healthcare providers about personal risk factors rather than avoiding hormone therapy based on outdated concerns. Women considering treatment should discuss their age, time since menopause onset, family history, and symptom severity to determine whether hormone therapy is appropriate for their individual situation.
